Douglas Berger psychiatrist Tokyo is an American board certified psychiatrist and is the Director of the Tokyo Meguro Counseling Center. He’s also fully bilingual in Japanese and English. Dr. Berger received his M.D. and psychiatry training from New York Medical College, and his Ph.D. from the Department of Psychosomatic Medicine at the Tokyo University School of Medicine. He speaks native-level Japanese. Dr. Berger utilizes a variety of approaches to psychiatry, which you can find here, and on the Tokyo Meguro Counseling Center’s home page.
Dr. Berger can be contacted by phone: 03-3716-6624 (+81-3-3716-6624 from outside of Japan). Please use this form if you wish to contact Dr. Douglas Berger psychiatrist in Tokyo.
Narcissists should feel rage when unpraised- Likely, the modest praise gave satisfaction-blush, and inflated praise gave proud feeling. The study's problems: subjects' age, validity of personality tests, unblinded nature of researchers, lack of placebo. https://t.co/59gLBhYuMX
NYT “Tell it about You Mother” suggests psychoanalysis caused brain changes https://t.co/pgQ8YqXBv3. There is 1 fMRI image of 1 patient, no results nor analysis & the 1-patient data is a personal contact from the authors to the NYT. NYT should rewrite. https://t.co/We7OmvxoYF
Sorry to interject economics, science, and politics, in our mental health tweeting. But if this is true then we can still save jobs and our coastlines! Its BIG stuff. Us: https://t.co/2rTavy34n4
There is indeed more acceptance of mental illness AT work, but not more acceptance of seeing a history of mental illness on an application FOR work. All else being equal, management will likely choose the person without problems. How to change this is the question.
The Army Study to Assess Risk and Resilience in Service members found 1/2 of soldiers had some mental disorder at enlistment: https://t.co/R6m6bs75NU It is challenging to mitigate morbidity as many persons enter the military with mental health problems. https://t.co/59gLBhYuMX
Medications previously tested in other indications may help treat CNS disorders: https://t.co/757bnbaLNx Even anti-cancer drugs are being looked at to treat schizophrenia. This is a great "economy of scale" use of clinical trials. Us: https://t.co/4EE55E1tzZ
Brexanolone is a GABAergic drug for post-partum depression that elevates allopreganolone: https://t.co/ALaXT3h6qb Antidepressants still need to be used in patients however & there is no head-to-head comparison of brexanolone vs. antidepressants yet. Us: https://t.co/6oRuH4YcOU
Effects of acupuncture are the same whether placed along the meridians or at random locations: https://t.co/4kGiSkQBsY Acupuncture studies can not be double-blinded, researchers know which patients receive real acupuncture, likely biasing the results. https://t.co/OIlRSavw02
Has CGT shown "efficacy"? https://t.co/wf3TZAv4tS -not if you think a study needs double-blinding, patient+therapist not just rater blind, and blind placebo as would the FDA to approve a medical treatment of a subjective psychiatric disorder like grief. https://t.co/GwwzyYyjaI
Bui and Shear coauthor “..CLINICAL INTERVIEW FOR COMPLICATED GRIEF…” https://t.co/hbPds7lVil Bui: says though the CG diagnosis is yet to be validated, “The SCI-CG can be used as validated instrument…” Ergo, we can validate an instrument even when diagnosis is not validated?
Bui: Complicated grief treatment (CGT) has “shown efficacy…across 3...trials” authored by Shear https://t.co/wf3TZAv4tS. Bui has worked with Shear, Director of the “Center for Complicated Grief”, which charge fees for workshops up to $600, https://t.co/h6XFgIwROp
Dr. Bui continues, "...studies have found no...differences between bereavement-related depressive syndromes and non-bereavement related depressive syndromes…The bereavement exclusion was dropped in DSM-5 …”: https://t.co/0ao28lbPRt What's going on here?
Dr. Bui: “Persistent Complex Bereavement Disorder PCBD, ” “has been shown to be distinct from mood, anxiety, and other trauma-related disorders despite.. overlap”. But, “…risk factors for PCBD are similar to those for other bereavement-related conditions: https://t.co/0ao28lbPRt
This move will also spur on use of other indications and targets in adults. I may also show add important information to adverse effect profiles. Us: https://t.co/8JFYE38tUu
The chart doesn't speak to the interaction of diseases-i.e., obesity and diabetes, or smoking and drinking w/mortality. Note, psychiatric conditions aren't on the graph, though they have strong correlations with the big killers. Morbidity is a crucial factor leading to morality.
Sudden Onset of Tics, Tantrums, Hyperactivity, and Lability: https://t.co/9GQYRHXzxk Excellent reminder to think of PANDAS when faced with these kinds of children, usually treated with amoxacillin and naproxen, & led by a pediatric neurologist. Us: https://t.co/sooQBqR2nb
This doesn't mean that "grandmother therapists" aren't helpful support- https://t.co/pMG2d9QGg5, but it hasn't been shown in a trial controlled for blinding to be more than support. Us: https://t.co/Fy4b1Rw61Q
In a depression trial, responder is defined as 50% improved- and depression can easily be assuaged a bit. Even a little hope for a specific intervention can make someone a "responder" in a depression trial like this one https://t.co/pMG2d9QGg5 on "grandmother therapists".
Having support from "grandmothers" is a great thing. But, because measurement of depression is subjective, trials need to be double-blind (patient & therapist blind), and it's impossible to double-blind a psychotherapy. See the study: https://t.co/pMG2d9QGg5
Study limited w/ONLY 8mice in each control & stress gp. Only 19 days of"chronic" stress is hard to correlate with humans who endure months or years of stress. Along w/surrogate markers, translation to a stress condition in humans is yet to be validated. Us:https://t.co/IJ5gU6GUPh
This is a timely topic. Toxic stress doesn't automatically mean someone will get a psychiatric illness, however, genetics of vulnerability as well as life-situation as an adult will have considerable influence. Us: https://t.co/oOTzE4A2YJ
Suicide is an outcome of an associated problem. The answer is better treatments and awareness of mood disorders, alcohol and drugs, social isolation, bullying, support for stressful life events & limiting access to lethal weapons. Us: https://t.co/dxTjUotW9q
We need to keep in perspective that CBT studies do not have patient or treater blind, nor do they have blind placebo control. It is impossible to fully filter-out expectation and hope in these studies where there is significant subjective element to severity rating.